Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Barbara Klencke Insider Profile
4 Followers
Barbara Klencke, CMO at Sierra Oncology, holds 0.00 shares in Sierra Oncology (Ticker: SRRA), holds ― shares in eFFECTOR Therapeutics (Ticker: EFTR), holds 55.00K shares in TScan Therapeutics (Ticker: TCRX).
Profitable Transactions
2 out of 3 Profitable Transactions
Average Return
+36.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Barbara Klencke holds in companies
Most Profitable Insider Trade
The most profitable trade made by Barbara Klencke
Barbara Klencke's Trading History
Sierra Oncology
Jul 01, 2022
―
Uninformative Sell
825.00K
$0.00
eFFECTOR Therapeutics
―
Director
―
―
TScan Therapeutics
Dec 18, 2023
Director
Informative Buy
25.40K
$440.55K
Xencor
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Barbara Klencke's performance on stock
You May Also Like
Barbara Klencke insider profile FAQ
What is the percentage of profitable transactions made by Barbara Klencke?
The percentage of profitable transactions made by Barbara Klencke is 67%.
What is the average return per transaction made by Barbara Klencke?
The average return per transaction made by Barbara Klencke is 36.80%.
What stocks does Barbara Klencke hold?
Barbara Klencke holds: SRRA, EFTR, TCRX, XNCR stocks.
What was Barbara Klencke’s latest transaction?
Barbara Klencke latest transaction was an Uninformative Sell of $825.00K.
What was Barbara Klencke's most profitable transaction?
Barbara Klencke’s most profitable transaction was an Informative Buy of TCRX stock on December 18, 2023. The return on the trade was 85.60%.
What is Barbara Klencke's role in Sierra Oncology?
Barbara Klencke's role in Sierra Oncology is CMO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.